Cargando…
Circulating Tumor Cells in Gastrointestinal Cancers: Current Status and Future Perspectives
Circulating tumor cells (CTCs), which are now defined as the “break away” cancer cells that derive from primary- or metastatic-tumor sites and present in the bloodstream, are considered to be the precursors of metastases. Considering the key role of CTCs in cancer progression, researchers are commit...
Autores principales: | Yang, Chaogang, Chen, Fangfang, Wang, Shuyi, Xiong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923205/ https://www.ncbi.nlm.nih.gov/pubmed/31921680 http://dx.doi.org/10.3389/fonc.2019.01427 |
Ejemplares similares
-
Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions
por: Lam, Rachel C. T., et al.
Publicado: (2022) -
Circulating tumor cells in neuroblastoma: Current status and future perspectives
por: Yang, Ran, et al.
Publicado: (2022) -
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021) -
Artificial Intelligence for Personalized Medicine in Thyroid Cancer: Current Status and Future Perspectives
por: Li, Ling-Rui, et al.
Publicado: (2021) -
In vitro models for head and neck cancer: Current status and future perspective
por: Moya-Garcia, Christian R., et al.
Publicado: (2022)